Cargando…

The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients

Non-alcoholic fatty liver disease (NAFLD) is related to metabolic syndrome via insulin resistance, where preventing disease progression is crucial in the management process. The study included 240 NAFLD patients with type 2 diabetes who were randomly allocated into empagliflozin 25 mg (EMPA group),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elhini, Sahar H., Wahsh, Engy A., Elberry, Ahmed A., El Ameen, Nadia F., Abdelfadil Saedii, Ahmed, Refaie, Shereen Mahmoud, Elsayed, Asmaa A., Rabea, Hoda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786599/ https://www.ncbi.nlm.nih.gov/pubmed/36558967 http://dx.doi.org/10.3390/ph15121516

Ejemplares similares

The preparedness and knowledge of pharmacists and general practitioners in managing human monkeypox: a highly spreading infectious disease
por: Elsayed, Asmaa A., et al.
Publicado: (2023)

Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy
por: Sultan, El-Zahraa M., et al.
Publicado: (2022)

Angiopoietin-like proteins 3, 4 and 8 are linked to cardiovascular function in naïve sub-clinical and overt hypothyroid patients receiving levothyroxine therapy
por: El Hini, Sahar Hossam, et al.
Publicado: (2021)

Oxytocin ameliorates cisplatin-induced nephrotoxicity in Wistar rats
por: Elberry, Ahmed A., et al.
Publicado: (2013)

Aerosol delivery aspects within a high-flow therapy system in COPD patients
por: Madney, Yasmin M., et al.
Publicado: (2021)

Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
por: Nadinskaia, Maria, et al.
Publicado: (2021)

Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
por: Mahmoud, Amr A. A., et al.
Publicado: (2014)

Potential effects of ursodeoxycholic acid on accelerating cutaneous wound healing
por: El-Hamoly, Tarek, et al.
Publicado: (2019)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

SGLT5 Reabsorbs Fructose in the Kidney but Its Deficiency Paradoxically Exacerbates Hepatic Steatosis Induced by Fructose
por: Fukuzawa, Taku, et al.
Publicado: (2013)

Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis
por: Zhou, Peipei, et al.
Publicado: (2023)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

The effect of Er, Cr:YSGG laser debonding on the bond strength of two ceramic materials to dentin
por: Abdel Sadek, Hoda M., et al.
Publicado: (2023)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
por: Lewis, Tamorah, et al.
Publicado: (2018)

Hemodialysis patients’ satisfaction with dialysis care: a cross-sectional prospective study conducted in a non-profitable care facility, Minia Egypt
por: Helmy, Noha H., et al.
Publicado: (2022)

Ursodeoxycholic acid production by Gibberella zeae mutants
por: Kollerov, Vyacheslav, et al.
Publicado: (2022)

Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development
por: Pearson, Talima, et al.
Publicado: (2019)

Correlation between International Normalized Ratio values and sufficiency of two different local hemostatic measures in anticoagulated patients
por: Amer, Mohamed Zaghlool, et al.
Publicado: (2014)

Insulin Resistance, Steatosis, and Fibrosis in Egyptian Patients with Chronic Hepatitis C Virus Infection
por: Ahmed, Ahlam M., et al.
Publicado: (2011)

Evaluating physicians’ awareness and prescribing trends regarding proton pump inhibitors: a cross-sectional study
por: Swed, Sarya, et al.
Publicado: (2023)

Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022)

Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects
por: Murakami, Masanori, et al.
Publicado: (2013)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

Cell-seeded tubular acellular matrix for replacing a long circumferential urethral defect in a canine model: Is it clinically applicable?
por: El-Tabey, Nasr, et al.
Publicado: (2012)

Impact of COVID-19 on digestive system: prevalence, clinical characteristics, outcome, and relation to the severity of COVID-19
por: Hashem, Walaa M., et al.
Publicado: (2022)

Expanding the Phenotypic Spectrum of APMR4 Syndrome Caused by a Novel Variant in LSS Gene and Review of Literature
por: Elaraby, Nesma M., et al.
Publicado: (2022)

Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study
por: Kotb, Magd Ahmed, et al.
Publicado: (2020)

The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients
por: El-Ghandour, Ahmed, et al.
Publicado: (2023)

Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia
por: AlWabel, Ahmed H, et al.
Publicado: (2022)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
por: Choi, S. W., et al.
Publicado: (1991)

Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
por: Torisu, Yuichi, et al.
Publicado: (2017)

Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy
por: Ughasoro, Maduka Donatus, et al.
Publicado: (2019)

Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice
por: Oh, Ah-Reum, et al.
Publicado: (2016)

Ursodeoxycholic acid attenuates the expression of proinflammatory cytokines in periodontal cells
por: Talebian, Reza, et al.
Publicado: (2020)

Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
por: Subramanian, Subbaya, et al.
Publicado: (2020)

1197. Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth
por: Alnezary, Faris, et al.
Publicado: (2020)

Ursodeoxycholic Acid May Inhibit Environmental Aging-Associated Hyperpigmentation
por: Moon, Ik Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8kfodvf7th2r8t7apait53169